Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide. Heart failure (HF), a major pathology of the myocardium, is characterized by impaired cardiac function that leads to an abnormal enlargement of the heart, known as hypertrophy. In the study of the molecular mechanisms of HF pathogenesis, animal models play a crucial role. To characterize induced HF in animal models, biochemical approaches, such as quantifying the concentration of biomarkers in blood serum, are extremely important. Here we report a new immunochemical test system based on the measurement of the concentration of the B-type natriuretic peptide, protein biomarker of HF and hypertrophy, that can be utilized for characterization of HF development in rats and serve as a tool for further BNP concentration analysis.


